Robert J. Mulroy, President and CEO at MERRIMACK PHARMACEUTICALS INC (MACK), sold 200,000 shares at $9.85 ($2.0M) on 2014-12-05, disclosed to the SEC on 2014-12-09.
Open-market sale of $2.0M MACK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.85 | 175,000 | $1.7M | 87.6% |
| 2 | $9.73 | 25,000 | $243K | 12.4% |
| Total | $9.84 avg | 200,000 | $2.0M | 100% |
| Filing → |
| MACK | SELL | 2015-02-20 | $1.6M | — | Filing → |
| MACK | BUY | 2014-05-07 | $32K | — | Filing → |
| MACK | BUY | 2013-12-05 | $146K | — | Filing → |